Skip to Main Content

Paper Details

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs.
Cancer Prev Res (Phila)
3
2022
Author NameAffiliation
Eduardo VilarThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2